Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
3.740
+0.535 (16.69%)
At close: Nov 4, 2024, 4:00 PM
3.690
-0.050 (-1.34%)
After-hours: Nov 4, 2024, 4:47 PM EST
Cardiff Oncology Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 25.5 | 21.66 | 16.35 | 11.94 | 130.98 | 10.2 | Upgrade
|
Short-Term Investments | 34.82 | 53.17 | 88.92 | 128.88 | - | - | Upgrade
|
Cash & Short-Term Investments | 60.32 | 74.82 | 105.27 | 140.82 | 130.98 | 10.2 | Upgrade
|
Cash Growth | -32.55% | -28.92% | -25.25% | 7.51% | 1184.72% | -10.98% | Upgrade
|
Receivables | 0.45 | 0.29 | 0.77 | 0.54 | 0.32 | 0.2 | Upgrade
|
Prepaid Expenses | 1.48 | 2.3 | 5.25 | 4.77 | 2.06 | 0.95 | Upgrade
|
Total Current Assets | 62.25 | 77.41 | 111.28 | 146.13 | 133.36 | 11.35 | Upgrade
|
Property, Plant & Equipment | 2.53 | 2.95 | 3.52 | 3.18 | 0.97 | 1.58 | Upgrade
|
Other Long-Term Assets | 1.27 | 1.28 | 1.39 | 0.24 | 0.4 | 0.16 | Upgrade
|
Total Assets | 66.05 | 81.64 | 116.19 | 149.54 | 134.73 | 13.09 | Upgrade
|
Accounts Payable | 5.11 | 1.97 | 1.96 | 1.44 | 1.37 | 0.66 | Upgrade
|
Accrued Expenses | 6.71 | 7.78 | 5.18 | 4.11 | 3.46 | 2.89 | Upgrade
|
Current Portion of Leases | 0.7 | 0.69 | 0.68 | 0.55 | 0.86 | 0.87 | Upgrade
|
Other Current Liabilities | - | - | - | 0.46 | 0.43 | 0.37 | Upgrade
|
Total Current Liabilities | 12.52 | 10.44 | 7.81 | 6.56 | 6.12 | 4.78 | Upgrade
|
Long-Term Leases | 1.14 | 1.46 | 2.04 | 2.57 | 0.01 | 0.86 | Upgrade
|
Other Long-Term Liabilities | - | - | - | - | 0.44 | 0.13 | Upgrade
|
Total Liabilities | 13.66 | 11.9 | 9.85 | 9.13 | 6.57 | 5.78 | Upgrade
|
Common Stock | 0.01 | 0 | 0 | 0 | 0 | 0.01 | Upgrade
|
Additional Paid-In Capital | 413.02 | 409.34 | 404.83 | 400.5 | 361.82 | 217.17 | Upgrade
|
Retained Earnings | -360.54 | -339.54 | -298.1 | -259.81 | -231.5 | -208.9 | Upgrade
|
Comprehensive Income & Other | -0.1 | -0.07 | -0.4 | -0.28 | -2.17 | -0.97 | Upgrade
|
Total Common Equity | 52.39 | 69.74 | 106.34 | 140.42 | 128.16 | 7.31 | Upgrade
|
Shareholders' Equity | 52.39 | 69.74 | 106.34 | 140.42 | 128.16 | 7.31 | Upgrade
|
Total Liabilities & Equity | 66.05 | 81.64 | 116.19 | 149.54 | 134.73 | 13.09 | Upgrade
|
Total Debt | 1.84 | 2.15 | 2.72 | 3.12 | 0.87 | 1.73 | Upgrade
|
Net Cash (Debt) | 58.48 | 72.67 | 102.55 | 137.7 | 130.11 | 8.47 | Upgrade
|
Net Cash Growth | -32.78% | -29.13% | -25.53% | 5.83% | 1436.34% | -26.06% | Upgrade
|
Net Cash Per Share | 1.31 | 1.63 | 2.35 | 3.53 | 6.23 | 1.42 | Upgrade
|
Filing Date Shares Outstanding | 46.55 | 44.68 | 44.68 | 43.31 | 37.05 | 10.21 | Upgrade
|
Total Common Shares Outstanding | 45.6 | 44.68 | 44.68 | 41.96 | 36.78 | 8.59 | Upgrade
|
Working Capital | 49.72 | 66.97 | 103.48 | 139.57 | 127.24 | 6.57 | Upgrade
|
Book Value Per Share | 1.15 | 1.56 | 2.38 | 3.35 | 3.48 | 0.85 | Upgrade
|
Tangible Book Value | 52.39 | 69.74 | 106.34 | 140.42 | 128.16 | 7.31 | Upgrade
|
Tangible Book Value Per Share | 1.15 | 1.56 | 2.38 | 3.35 | 3.48 | 0.85 | Upgrade
|
Machinery | 2.48 | 2.42 | 2.12 | 1.86 | 1.67 | 1.52 | Upgrade
|
Leasehold Improvements | 2.57 | 2.57 | 2.56 | 1.96 | 1.96 | 1.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.